1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. EXELIXIS INC
51.29 1.83 (3.70%)
3.2M
XNAS Volume

XNAS 13 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Board Meeting
The next board meeting for Exelixis Inc is on 20 May 2026 for the purpose of 2026 Stifel Virtual Targeted Oncology Forum See details

Exelixis Inc - EXEL - stock price prediction, stock price target, analyst ratings from 20 analysts

Exelixis Inc has a share price target of US$ 49, revenue growth forecast of 11.8%, and profit growth estimate of 4.3% for FY26, based on top 20 analyst calls.